Bitcoin trades below $90,000 after rejecting major resistance, with technical signals pointing toward $70,000 and rising bearish pressure.Bitcoin trades below $90,000 after rejecting major resistance, with technical signals pointing toward $70,000 and rising bearish pressure.

4 Red Months in a Row? Bitcoin Faces Rare 2018-Style Crash Signal

3 min read

Bitcoin (BTC) is trading under pressure after failing to break a key resistance level. The asset remains below $90,000, with technical patterns suggesting a deeper move toward $70,000 in the coming days or weeks.

Price Fails at Key Resistance

Bitcoin was rejected at the $94,000 to $98,000 range after several attempts to break through it. This area acted as neckline resistance in a larger technical setup. After the rejection, the price moved sharply lower, confirming a bearish trend. A failed Head and Shoulders pattern and a bear flag breakdown support the current move.

The asset hovers around $88,000 at press time. Analysts are tracking three support levels: $80,000, $75,000, and $70,000. According to analyst Crypto Patel, these levels match the expected move from the breakdown, which points to a possible 22% decline. The trend is considered bearish until the price regains and holds above $92,000.

Over the past seven days, Bitcoin has fallen more than 6%. Despite a small recovery of under 1% in the last 24 hours, the asset remains near its lowest point in a month. The market is waiting for a decision from the US Federal Reserve and earnings reports from major tech companies. Both events could affect sentiment across risk assets.

Bitcoin’s decline has also followed a series of large liquidations in the derivatives market. These forced sell-offs added pressure during a week marked by wider uncertainty in global markets, including sharp moves in currencies and US bonds.

Key Technical Levels in Focus

According to Material Indicators, a CoinMarketCap contributor, the 50-day simple moving average near $90,000 is acting as resistance. Liquidity worth over $50 million is sitting above that level, making it harder for bulls to regain control. The 21-day moving average is near $91,500 and could add to the resistance if the price rises again.

A crossover between the 21-day and 50-day moving averages is expected next month. If the shorter average crosses below the longer one, it could add to the bearish pressure.

In addition, another analyst, BitBull, reports that Bitcoin is sitting near the Active Investor Mean at $87,500. This often acts as a decision point—if held, it may attract support. If lost, the asset may fall toward $80,700, which has historically served as a deeper support level.

Short-term holder cost basis is above $96,000, meaning many are now in a loss. This creates selling pressure above the current price. Long-term holders, by contrast, remain in profit, with their average cost closer to $56,000.

Crypto analyst Aman also observed, “$BTC is on the edge of a 4th consecutive red month,” a rare pattern last seen in 2018. As we previously reported, market analysts remain cautious about current price levels, noting that recent lows may not mark a final bottom.

The post 4 Red Months in a Row? Bitcoin Faces Rare 2018-Style Crash Signal appeared first on CryptoPotato.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29